Compounds > 7,8-(methylenedioxy)-14-hydroxyberbane
Page last updated: 2024-09-03

7,8-(methylenedioxy)-14-hydroxyberbane and neuropeptide y

7,8-(methylenedioxy)-14-hydroxyberbane has been researched along with neuropeptide y in 1 studies

Compound Research Comparison

Studies
(7,8-(methylenedioxy)-14-hydroxyberbane)		Trials
(7,8-(methylenedioxy)-14-hydroxyberbane)		Recent Studies (post-2010)
(7,8-(methylenedioxy)-14-hydroxyberbane)		Studies
(neuropeptide y)		Trials
(neuropeptide y)		Recent Studies (post-2010) (neuropeptide y)
400010,6631522,269

Protein Interaction Comparison

ProteinTaxonomy7,8-(methylenedioxy)-14-hydroxyberbane (IC50)neuropeptide y (IC50)
Neuropeptide Y receptor type 1Homo sapiens (human)0.0014
Neuropeptide Y receptor type 2Homo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freund, TF; Katona, I; Vizi, ES1

Other Studies

1 other study(ies) available for 7,8-(methylenedioxy)-14-hydroxyberbane and neuropeptide y

ArticleYear
Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung.
    European journal of pharmacology, 2001, Nov-16, Volume: 431, Issue:2

    Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Berberine; Bronchi; Electric Stimulation; Female; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Lung; Male; Neuropeptide Y; Norepinephrine; Receptors, Cannabinoid; Receptors, Drug; Receptors, Presynaptic; Tritium

2001